Original Article

Central Corneal Thickness, Anterior Chamber Depth, and Pupil Diameter Measurements Using Visante OCT, Orbscan, and Pentacam

Ahmet Taylan Yazici, MD; Ercument Bozkurt, MD; Cengiz Alagoz, MD; Nese Alagoz, MD; Gokhan Pekel, MD; Vedat Kaya, MD; Omer Faruk Yilmaz, MD

  • Journal of Refractive Surgery
  • February 2010 - Volume 26 · Issue 2: 127-133
  • DOI: 10.3928/1081597X-20100121-08
Rights and Permissions

Abstract

Purpose:

To evaluate the agreement among three different optical methods in measuring anterior chamber depth (ACD), central corneal thickness (CCT), and pupil diameter.

Methods:

One hundred eyes of 50 healthy patients (25 men, 25 women) were enrolled in the study. Mean patient age was 25 years (range: 21 to 32 years). Exclusion criteria were history of any intraocular or corneal surgery, contact lens wear, corneal anomalies, and spherical refraction >5.00 diopters (D) or cylindrical refraction >2.00 D. All measurements were done by the same operator under mesopic light conditions and repeated using three different optical methods: Visante optical coherence tomography (OCT) (Carl Zeiss Meditec), Orbscan (Bausch & Lomb), and Pentacam (Oculus Optikgeräte GmbH).

Results:

Mean CCT as measured by Visante OCT, Orbscan, and Pentacam was 529±30.5 μm, 554±32.7 μm, and 552±29.3 μm, respectively. Mean ACD values were 2.94±0.34 mm, 2.84±0.33 mm, and 2.98±0.33 mm, respectively. Mean pupil diameter measurements were 4.87±1.09 mm, 4.0±0.67 mm, and 3.05±0.59 mm, respectively. The Visante OCT measured CCT thinner and Orbscan measured ACD shallower than the other two methods. All three methods measured pupil diameters significantly different.

Conclusions:

This study found some statistically significant but clinically insignificant differences among the optical methods assessed. The differences are small and do not influence decisions for refractive surgery in clinical practice.

AUTHORS

From Beyoglu Eye Research and Training Hospital, Istanbul, Turkey.

The authors have no financial or proprietary interest in the materials presented herein.

Correspondence: Nese Alagoz, MD, Beyoglu Eye Research and Training Hospital, Bereketzade Camii Sok, Kuledibi - Beyoglu, Istanbul, Turkey. Tel: 90 5054612774; E-mail: alagoznese@gmail.com

doi: 10.3928/1081597X-20100121-08

Healio is intended for health care provider use and all comments will be posted at the discretion of the editors. We reserve the right not to post any comments with unsolicited information about medical devices or other products. At no time will Healio be used for medical advice to patients.

[X]